CLINICAL_TRIALS
trial_result
· 2017-07-02
Clinical Trial Update: Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients [Phase 2]
Summary
Phase 2 trial evaluating temozolomide alone or with pegylated interferon-alpha 2b (PGI) in melanoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2017-07-02